Clinical Trial Update: Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update of denufosol tetrasodium for cystic fibrosis lung disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Denufosol Tetrasodium (denufosol)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED